Selection bias and subject refusal in a cluster-randomized controlled trial
2017 · BMC Medical Research Methodology · 19 citations
https://doi.org/10.1186/s12874-017-0368-7
Y
Yinghui Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
131
Papers
2.6K
Citations
21
h-index
46
i10-index
Yinghui Xu is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Colorectal Cancer Screening and Detection & Gastric Cancer Management and Outcomes. The author has an h-index of 21, co-authored 112 publications.
ORCID: 0000-0002-5088-5092Papers by this author
worksGenetic variants in <i>RORA</i> and <i>DNMT1</i> associated with cutaneous melanoma survival
2018 · International Journal of Cancer · 16 citations
https://doi.org/10.1002/ijc.31243
Genetic variants in the genes encoding rho GTPases and related regulators predict cutaneous melanoma‐specific survival
2017 · International Journal of Cancer · 9 citations
https://doi.org/10.1002/ijc.30785
Genetic variants in the calcium signaling pathway genes are associated with cutaneous melanoma-specific survival
2018 · Carcinogenesis · 8 citations
https://doi.org/10.1093/carcin/bgy188
FMO2 Prevents Pathological Cardiac Hypertrophy by Maintaining the ER-Mitochondria Association Through Interaction With IP3R2-Grp75-VDAC1
2025 · Circulation · 8 citations
https://doi.org/10.1161/circulationaha.124.072661
Successful treatment of Afatinib plus Apatinib using for a lung adenocarcinoma patient with HER-2 V659D mutation: a rare case report
2021 · Anti-Cancer Drugs · 4 citations
https://doi.org/10.1097/cad.0000000000000995
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat